0000000000482714

AUTHOR

Margarita Ribó-coll

showing 3 related works from this author

Mediterranean Diet and Physical Activity Decrease the Initiation of Cardiovascular Drug Use in High Cardiovascular Risk Individuals: A Cohort Study

2021

Our aim was to assess whether long-term adherence to a Mediterranean diet (MedDiet) and leisure-time physical activity (LTPA) were associated with a lower initiation of cardiovascular drug use. We studied the association between cumulative average of MedDiet adherence and LTPA and the risk of cardiovascular drug initiation in older adults at high cardiovascular risk (PREvención con DIeta MEDiterránea trial participants) non-medicated at baseline: glucose-lowering drugs (n = 4437), antihypertensives (n = 2145), statins (n = 3977), fibrates (n = 6391), antiplatelets (n = 5760), vitamin K antagonists (n = 6877), antianginal drugs (n = 6837), and cardiac glycosides (n = 6954). One-point increas…

StatinMediterranean dietPhysiologymedicine.drug_classClinical Biochemistryphysical activityFibrateantiplatelet drugs030204 cardiovascular system & hematologyPharmacologyLower riskBiochemistryMetabolic equivalentArticlestatinscardiac glycosides03 medical and health sciences0302 clinical medicineMediterranean cookingMediterranean dietCuina mediterràniamedicine030212 general & internal medicinevitamin K epoxide reductase inhibitorsMolecular BiologyCardiac glycosideglucose-lowering drugsbusiness.industrylcsh:RM1-950mediterranean dietCell BiologyVitamin K antagonistPhysical fitnessCardiovascular agentslcsh:Therapeutics. Pharmacologyantihypertensive drugsantianginal drugsfibratesbusinessCohort studymedicine.drugCondició físicaMedicaments cardiovasculars
researchProduct

Mediterranean Diet Decreases the Initiation of Use of Vitamin K Epoxide Reductase Inhibitors and Their Associated Cardiovascular Risk: A Randomized C…

2020

Our aim is to assess whether following a Mediterranean Diet (MedDiet) decreases the risk of initiating antithrombotic therapies and the cardiovascular risk associated with its use in older individuals at high cardiovascular risk. We evaluate whether participants of the PREvenci&oacute

Male0301 basic medicineVitamin KTime FactorsMediterranean diet030204 cardiovascular system & hematologyPharmacology4-HydroxycoumarinsDiet Mediterraneanchemistry.chemical_compound0302 clinical medicinepreventionAntithromboticNutsEnzyme InhibitorsDiet Fat-RestrictedUncategorizedNutrition and DieteticsMiddle AgedClopidogrelVitamines KCardiovascular Diseasesrandomized controlled trialsRandomized controlled trialsPlatelet aggregation inhibitorDietaFemaleVitamin K epoxide reductaselcsh:Nutrition. Foods and food supplymedicine.druglcsh:TX341-641Article03 medical and health sciencesMediterranean cookingFibrinolytic AgentsMediterranean dietVitamin K Epoxide ReductasesPlatelet aggregation inhibitorsCuina mediterràniamedicineHumansTiclopidineplatelet aggregation inhibitorsOlive OilAgedMediterranean DietMalalties cardiovascularsbusiness.industryPreventionWarfarinDiet4-hydroxycoumarins030104 developmental biologychemistryHeart Disease Risk FactorsbusinessFood Science
researchProduct

Mediterranean diet and antihypertensive drug use: a randomized controlled trial

2021

Objective To examine in older individuals at high cardiovascular risk whether following a Mediterranean diet decreased the necessity of antihypertensive drugs and modulated their associated cardiovascular risk. Methods In the PREvencion con DIeta MEDiterranea study, we assessed whether volunteers randomly allocated to an intervention with a Mediterranean diet enriched with extra-virgin olive oil or nuts (relative to a low-fat control diet) disclosed differences in the risk of: initiating antihypertensive medication in nonusers at baseline (n = 2188); and escalating therapy in participants using one, two, or three drugs at baseline (n = 2361, n = 1579, and n = 554, respectively). We also ass…

medicine.medical_specialtyMediterranean dietPhysiologymedicine.drug_classPsychological intervention030204 cardiovascular system & hematologyDiet MediterraneanLower risklaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRisk FactorslawInternal medicineInternal MedicinemedicineHumansNuts030212 general & internal medicineAntihypertensive drugOlive OilAntihypertensive AgentsAgedbusiness.industryIncidence (epidemiology)Hazard ratioCardiovascular DiseasesCardiology and Cardiovascular MedicinebusinessOlive oilJournal of Hypertension
researchProduct